EPI|LIFESTYLE 2019 Scientific Sessions
Epidemiology and Prevention | Lifestyle and Cardiometabolic Health
March 5 – 8, 2019
The Westin Galleria | Houston, Texas
Take advantage of Early Registration prices!

See more details on our Registration and Housing page
Abstract Submission
Abstract submission is now closed.


Click on a day/date below to expand or collapse; or print a downloadable copy of the EPI Lifestyle 2019 Schedule at a Glance (PDF).

March 5 Schedule
Time Activity
1:00 p.m – 5:00 p.m. Registration
5:00 p.m. – 6:00 p.m. Poster Session 1

March 6 Schedule
Time Activity
7:00 a.m – 8:00 a.m. Refreshment/Coffee
8:00 a.m. – 9:30 a.m. Session 1
President's Welcome and Opening Remarks
Theme: Genes, Behavior and Environment: Putting The Pieces Together
Genes - Eric Boerwinkle, PhD
Behavior - Leslie A. Lytle, PhD
Environment - Michael Jerrett, PhD
10:00 a.m. – 10:30 a.m. Refreshment Break
10:30 a.m. – 12:00 p.m. Session 2: Intersection of Behavior and OMICS
12:00 p.m. – 1:30 p.m. Lifestyle Council Annual Business Meeting
Networking Luncheon and Early Career Session
1:30 p.m. – 3:00 p.m. Session 3: Risk Prediction
1:00 p.m. – 3:00 p.m. NHLBI Trainee Session
3:00 p.m. – 3:30 p.m. Refreshment Break
3:30 p.m. – 5:00 p.m. Session 4: Health Promotion and Disease Prevention
3:30 p.m. – 5:00 p.m. NHLBI Trainee Session Continued
5:00 p.m. – 7:00 p.m. Poster Session 2
7:00 p.m. – 8:00 p.m. Hearts Diversity Reception
Hosted by the Council of Epidemiology & Prevention

March 7 Schedule
6:15 a.m – 7:00 a.m.Fun Run
7:00 a.m – 8:30 a.m.Refreshment/Coffee
7:00 a.m – 8:30 a.m.Lifestyle Early Career Morning Session
3-Minute Thesis Competition (3MT™)
8:30 a.m. – 5:00 p.m.Workplace Health Session
8:30 a.m. – 10:00 a.m.Session 5
(8:30 a.m. – 9:00 a.m.)
The David Kritchevsky Memorial Lecture

(9:00 a.m. – 10:00 a.m.)
Cardiovascular Biomarkers
10:00 a.m. – 10:30 a.m.Refreshment Break
Connection Corner
10:30 a.m. – 12:00 p.m.Session 6
Concurrent A: Hot Off the Press
Concurrent B: Lifecourse Epidemiology
12:00 p.m. – 1:30 p.m.EPI Council Annual Business Meeting
Networking Luncheon and Early Career Session
1:30 p.m. – 3:00 p.m.Session 7: Stamler Award Finalists
3:00 p.m. – 3:30 p.m.Refreshment Break
Connection Corner
3:30 p.m. – 5:00 p.m.Session 8: ASPC Annual Debate
5:00 p.m. – 7:00 p.m.Poster Session 3
7:00 p.m. – 8:00 p.m.Joint Council Dinner

March 8 Schedule
7:00 a.m – 8:30 a.m.Refreshment/Coffee
7:00 a.m – 8:30 a.m.EPI Early Career Morning Session
8:30 a.m. – 10:00 a.m.Session 9
(8:30 a.m. – 9:00 a.m.)
Richard D. Remington Methodology Lecture

(9:00 a.m. – 10:00 a.m.)
Diabetes and Obesity
10:00 a.m. – 10:30 a.m.Refreshment Break
Connection Corner
10:30 a.m. – 12:00 p.m.Session 10: Physical Activity Guidelines
Physical Activity Guidelines and What Is New - Janet E. Fulton, PhD, FAHA
Oral Abstracts
Putting the Guidelines in Practice and What Are the Research Needs? - William E. Kraus, MD, FAHA, FACC, FACSM
12:00 p.m. – 1:30 p.m.Early Career Roundtable Luncheon
1:30 p.m. – 3:00 p.m.Session 11
(1:30 p.m. – 2:00 p.m.)
The William B. Kannel, MD Memorial Lectureship in Preventative Cardiology

(2:00 p.m. – 3:00 p.m.)

3:00 p.m.

EPI/Lifestyle Program Information

The primary goal of EPI/Lifestyle 2019 Scientific Sessions is to promote the development and application of translational and population science to prevent heart disease and stroke and foster cardiovascular health. The Councils on Epidemiology and Prevention (EPI) and Lifestyle and Cardiometabolic Health (Lifestyle) jointly planned the EPI/Lifestyle 2019 Scientific Sessions. The sessions focus on risk factors, obesity, nutrition, physical activity, genetics, metabolism, biomarkers, subclinical disease, clinical disease, healthy populations, global health, and prevention-oriented clinical trials.

The program is designed to present new findings on:

  • Cardiovascular disease prevention trials
  • Causes and mechanisms of health factors, subclinical, and clinical cardiovascular diseases
  • Relationships of nutrition (diet) and physical activity (fitness) with cardiometabolic health
  • Relationships of obesity, diabetes, and renal disease with cardiometabolic health
  • Genetic and environmental epidemiology of cardiometabolic health
  • Effects of lifestyle interventions on cardiometabolic disease and its health factors
  • Population trends in cardiovascular diseases and their health factors
  • Global cardiovascular health

The program also will provide participants with the opportunity to learn current information about:

  • Advances in measuring diet and physical activity
  • Advances in techniques in preventive cardiology
  • Behavioral strategies to promote and sustain lifestyle modifications
  • Outcomes research and guideline development related to cardiovascular health
  • Advances in methods relevant to observational studies, clinical trials and population surveillance

The program includes presentations of new high-quality, high-impact research, organized around oral, moderated poster, and poster abstract presentations. Special translational science lectures and debates address current issues relevant to cardiometabolic health and preventive cardiology. This format maximizes the opportunities for thought-provoking multidisciplinary interactions across a wide spectrum of scientists, junior and established. The sessions are designed to enhance the careers of young and early mid-career investigators and practitioners committed to the promotion of cardiometabolic health.

The conference is designed to benefit researchers as well as public health practitioners and clinicians. The meeting should appeal to physicians, epidemiologists, dietitians, nutritional scientists, exercise physiologists, behavioral scientists, biostatisticians, pharmacists, physician assistants, nurses, school health professionals and other health scientists.

  1. Recognize opportunities to address modifiable risk factors for CVD, to help meet AHA components of ideal cardiovascular health.
  2. Discuss the causes and health consequences of continuing disparities in CVD risk factors among certain racial/ethnic, age, gender, and socioeconomic groups to help meet the AHA 2020 goals for improved cardiovascular health.
  3. Discuss current guidelines and research needs related to primordial and primary CVD prevention in children and adolescents.
  4. Explain the concept of precision medicine and identify opportunities and applications for precision medicine in CVD prevention and treatment.
  5. Identify educational opportunities for early-career cardiologists regarding career pathways and opportunities for research in cardiovascular epidemiology and prevention.